DE602007008932D1 - Verfahren zum nachweis einer aktivierung des immunsystems oder des ausmasses von zelltod - Google Patents

Verfahren zum nachweis einer aktivierung des immunsystems oder des ausmasses von zelltod

Info

Publication number
DE602007008932D1
DE602007008932D1 DE602007008932T DE602007008932T DE602007008932D1 DE 602007008932 D1 DE602007008932 D1 DE 602007008932D1 DE 602007008932 T DE602007008932 T DE 602007008932T DE 602007008932 T DE602007008932 T DE 602007008932T DE 602007008932 D1 DE602007008932 D1 DE 602007008932D1
Authority
DE
Germany
Prior art keywords
activation
extent
immune system
cell death
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008932T
Other languages
English (en)
Inventor
Stefan Margraf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leukocare AG
Original Assignee
Leukocare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leukocare AG filed Critical Leukocare AG
Publication of DE602007008932D1 publication Critical patent/DE602007008932D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE602007008932T 2006-09-29 2007-10-01 Verfahren zum nachweis einer aktivierung des immunsystems oder des ausmasses von zelltod Active DE602007008932D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82757106P 2006-09-29 2006-09-29
PCT/EP2007/008523 WO2008037499A2 (en) 2006-09-29 2007-10-01 Method for the detection of an activation of the immune system or the extent of cell death

Publications (1)

Publication Number Publication Date
DE602007008932D1 true DE602007008932D1 (de) 2010-10-14

Family

ID=39032248

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008932T Active DE602007008932D1 (de) 2006-09-29 2007-10-01 Verfahren zum nachweis einer aktivierung des immunsystems oder des ausmasses von zelltod

Country Status (6)

Country Link
US (1) US20090298078A1 (de)
EP (1) EP2078096B1 (de)
JP (1) JP5016676B2 (de)
AT (1) ATE479779T1 (de)
DE (1) DE602007008932D1 (de)
WO (1) WO2008037499A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3170924A1 (en) * 2007-10-02 2009-04-09 Labrador Diagnostics Llc Modular point-of-care devices and uses thereof
WO2011008985A2 (en) * 2009-07-15 2011-01-20 Georgia Tech Research Corporation Methods and compositions for improved delivery of therapeutic and diagnostic agents
US20130183662A1 (en) * 2010-04-22 2013-07-18 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Means and methods for identifying an increased risk of systemic lupus erythematosus (sle) patients for developing renal manifestations
JP2016519761A (ja) 2013-03-15 2016-07-07 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ 好中球細胞外トラップにおけるプロテアーゼの基質プロファイリング

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705365A (en) * 1995-06-07 1998-01-06 Gen-Probe Incorporated Kits for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product
JP2007529758A (ja) * 2004-03-19 2007-10-25 ユー．エス． ジェノミクス， インコーポレイテッド 単一分子の検出のための組成物および方法
US7598390B2 (en) * 2005-05-11 2009-10-06 Life Technologies Corporation Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
FR2904833A1 (fr) * 2006-08-11 2008-02-15 Bioquanta Sarl Procede de dosage d'acide nuclieque par fluorescence

Also Published As

Publication number Publication date
WO2008037499A2 (en) 2008-04-03
JP5016676B2 (ja) 2012-09-05
ATE479779T1 (de) 2010-09-15
JP2010505099A (ja) 2010-02-18
WO2008037499A3 (en) 2008-05-15
EP2078096B1 (de) 2010-09-01
US20090298078A1 (en) 2009-12-03
EP2078096A2 (de) 2009-07-15

Similar Documents

Publication Publication Date Title
ATE442590T1 (de) Verfahren zur schnelldiagnose von zielen in menschlichen kírperflüssigkeiten
WO2014144713A3 (en) Methods of sequencing the immune repertoire
ATE501280T1 (de) Verfahren zum nachweis eines analyten in einer biologischen matrix
CO6680668A2 (es) Ensayos biomarcadores para detectar o medir inhibición de actividad quinasa tor
GB2467467C (en) TAZ/WWTR1 for diagnosis and treatment of cancer
CA2726067A1 (en) Detection meter and mode of operation
MY183402A (en) Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof
EA201490999A1 (ru) Способ проведения количественных анализов
ATE507309T1 (de) Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung
WO2009055823A3 (en) Method to predict responsiveness of breast cancer to polyaminetype chemotherapy
ATE479779T1 (de) Verfahren zum nachweis einer aktivierung des immunsystems oder des ausmasses von zelltod
EP2662453A3 (de) Nachweis und Behandlung von Schizophrenie
DE502006002073D1 (de) Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen
EA201490909A1 (ru) Интеллектуальные метки - наночастицы для применения при подземных работах
WO2015059487A3 (en) Detection of cleavage activity of an enzyme
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
JP2011518338A5 (de)
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
WO2009022988A3 (en) Vhz for diagnosis and treatment of cancer
AR104805A1 (es) Métodos y composiciones para evaluar la capacidad de respuesta de los cánceres a los inhibidores de bet
BR112012009023A2 (pt) método pra detecção. diferenciação e identificação de eubactérias específica de táxons em uma amostra biológica por meio de técnicas de análise de sequenciamento e kit
MX2011009387A (es) Elemento de prueba para analizar un fluido corporal y metodo para su medicion.
DE112011104026A5 (de) Schnelltest zum qualitativen und/oder quantitativen Bestimmen von in Körperflüssigkeit enthaltenen Antikörpern gegen humane Papillomviren sowie Vorrichtung zum Durchführen des Schnelltests
WO2010000467A8 (en) Asc as a marker for lung cancer